Pancreatic cells wrapped in a biomaterial could be key to the next stage in diabetes management. The Cardiovascular Innovation Institute, has received a $1.3 million grant from the NIH to study this type of pancreatic cell transplants.
If successful, the transplants could be used as a means for managing cardiovascular disease and diabetes, the university said in a news release.
The cell transplant process involves encasing pancreatic cells in a porous biomaterial that protects cells from the immune system but allows glucose and insulin to pass through the material to keep the cells functioning while awaiting transplantation.
Add Comment |
June 6th, 2008
